0.599
price up icon0.18%   0.0011
after-market Dopo l'orario di chiusura: .59 -0.009 -1.50%
loading
Precedente Chiudi:
$0.5979
Aprire:
$0.583
Volume 24 ore:
195.65K
Relative Volume:
0.18
Capitalizzazione di mercato:
$37.61M
Reddito:
$11.03M
Utile/perdita netta:
$-44.24M
Rapporto P/E:
-0.9661
EPS:
-0.62
Flusso di cassa netto:
$-42.61M
1 W Prestazione:
+3.65%
1M Prestazione:
-18.05%
6M Prestazione:
-40.69%
1 anno Prestazione:
-33.41%
Intervallo 1D:
Value
$0.5815
$0.62
Intervallo di 1 settimana:
Value
$0.5327
$0.669
Portata 52W:
Value
$0.5327
$1.90

Hyperfine Inc Stock (HYPR) Company Profile

Name
Nome
Hyperfine Inc
Name
Telefono
866-796-6767
Name
Indirizzo
351 NEW WHITFIELD STREET, GUILFORD
Name
Dipendente
111
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-17
Name
Ultimi documenti SEC
Name
HYPR's Discussions on Twitter

Confronta HYPR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
HYPR
Hyperfine Inc
0.599 45.93M 11.03M -44.24M -42.61M -0.62
Medical Devices icon
ABT
Abbott Laboratories
132.85 231.49B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.50 154.81B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
382.35 145.13B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
82.41 108.21B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.73 44.64B 5.54B 4.18B 623.10M 7.00

Hyperfine Inc Stock (HYPR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-08-11 Downgrade Wells Fargo Overweight → Equal Weight
2022-05-31 Iniziato Evercore ISI Outperform
2022-04-14 Iniziato Wells Fargo Overweight

Hyperfine Inc Borsa (HYPR) Ultime notizie

pulisher
May 28, 2025

Hyperfine Gets FDA Clearance For Optive AI Software, Marking Major Upgrade To Swoop MRI Imaging - Nasdaq

May 28, 2025
pulisher
May 28, 2025

FDA OKs Hyperfine’s Optive AI Software for Swoop MR - Medical Product Outsourcing

May 28, 2025
pulisher
May 28, 2025

Hyperfine Announces FDA Clearance Of Optive AI(TM) Software - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Hyperfine announces FDA clearance of next-generation software - TipRanks

May 28, 2025
pulisher
May 28, 2025

Hyperfine unveils advanced AI software for portable MRI By Investing.com - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

Hyperfine unveils advanced AI software for portable MRI - Investing.com

May 28, 2025
pulisher
May 28, 2025

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System - Business Wire

May 28, 2025
pulisher
May 24, 2025

Hyperfine Chairperson R. Scott Huennekens Resigns - MSN

May 24, 2025
pulisher
May 19, 2025

Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 19, 2025
pulisher
May 19, 2025

Hyperfine Holds Annual Stockholders Meeting - TipRanks

May 19, 2025
pulisher
May 19, 2025

B. Riley Has Optimistic Outlook of Hyperfine Q3 Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

B. Riley Cuts Hyperfine (NASDAQ:HYPR) Price Target to $1.00 - Defense World

May 18, 2025
pulisher
May 15, 2025

Hyperfine Inc. Earnings Call: Transition and Growth - TipRanks

May 15, 2025
pulisher
May 15, 2025

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference - 01net

May 15, 2025
pulisher
May 15, 2025

Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Price Target Lowered | HYPR Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Hyperfine price target lowered to $1 from $1.20 at B. Riley - TipRanks

May 15, 2025
pulisher
May 15, 2025

B. Riley Reduces Price Target for Hyperfine (HYPR) After Sales M - GuruFocus

May 15, 2025
pulisher
May 15, 2025

B. Riley Lowers Price Target on Hyperfine to $1 From $1.20, Keeps Buy Rating - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Pri - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 14, 2025
pulisher
May 14, 2025

Wells Fargo Updates Price Target and Rating for HYPR | HYPR Stoc - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Hyperfine (HYPR) Reports Lower Q1 Revenue, Optimistic About Futu - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Hyperfine’s net loss for Q1 2025 hits USD 9.4M - Medical Buyer

May 14, 2025
pulisher
May 14, 2025

Hyperfine outlines 10%–20% revenue growth for 2025 as new product launches and office market entry drive diversification - MSN

May 14, 2025
pulisher
May 14, 2025

Hyperfine Q1 2025 Earnings Call Transcript - MarketBeat

May 14, 2025
pulisher
May 14, 2025

Hyperfine, Inc. Reports Q1 2025 Financial Results - TipRanks

May 14, 2025
pulisher
May 13, 2025

Hyperfine reports Q1 EPS (12c), consensus (12c) - TipRanks

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations - Investing.com

May 13, 2025
pulisher
May 13, 2025

Hyperfine Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results - Investing.com Australia

May 13, 2025
pulisher
May 13, 2025

Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Hyperfine Inc (HYPR) Q1 2025 Earnings: EPS Meets Estimate at -$0 - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Hyperfine Inc Files For Offering Of Up To $50 Million Of Shares Of Class A Common Stock - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Hyperfine, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Hyperfine, Inc. Reports First Quarter 2025 Financial Results - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Hyperfine Inc (HYPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus

May 13, 2025
pulisher
May 12, 2025

​Chipiron building ultra-low portable MRI scanner following $17M raise - BioWorld MedTech

May 12, 2025
pulisher
May 11, 2025

Hyperfine (HYPR) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Boosts Stock Holdings in Hyperfine, Inc. (NASDAQ:HYPR) - Defense World

May 07, 2025
pulisher
Apr 29, 2025

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 - Business Wire

Apr 29, 2025
pulisher
Apr 15, 2025

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - 01net

Apr 15, 2025
pulisher
Apr 15, 2025

Hyperfine Enrolls First Patients in Portable MRI Evaluation Study - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Hyperfine enrolls initial patients in NEURO PMR study - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Revolutionary Portable MRI Secures Medicare Coverage as Major Clinical Trial Launches - Stock Titan

Apr 15, 2025
pulisher
Apr 15, 2025

Hyperfine (NASDAQ:HYPR) Stock Price Up 0.5% – Should You Buy? - Defense World

Apr 15, 2025
pulisher
Apr 09, 2025

HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView

Apr 09, 2025
pulisher
Mar 28, 2025

HYPR stock touches 52-week low at $0.76 amid market challenges - Investing.com

Mar 28, 2025
pulisher
Mar 25, 2025

Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN

Mar 25, 2025
pulisher
Mar 24, 2025

Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia

Mar 24, 2025

Hyperfine Inc Azioni (HYPR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Hyperfine Inc Azioni (HYPR) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
TEISSEYRE THOMAS
Chief Operating Officer
Feb 18 '25
Sale
1.20
3,237
3,884
84,990
TEISSEYRE THOMAS
Chief Operating Officer
Nov 18 '24
Sale
0.85
2,800
2,380
88,227
TEISSEYRE THOMAS
Chief Operating Officer
Aug 16 '24
Sale
1.05
2,746
2,883
91,027
$323.85
price up icon 0.09%
medical_devices STE
$245.00
price up icon 0.00%
medical_devices SNN
$28.82
price up icon 0.73%
$71.53
price up icon 0.53%
$84.86
price down icon 2.44%
medical_devices EW
$77.73
price up icon 1.40%
Capitalizzazione:     |  Volume (24 ore):